| Reactive astrocyte nomenclature, definitions, and future directions C Escartin, E Galea, A Lakatos, JP O’Callaghan, GC Petzold, ... Nature neuroscience 24 (3), 312-325, 2021 | 1526 | 2021 |
| Astrocyte biomarkers in Alzheimer’s disease SF Carter, K Herholz, P Rosa-Neto, L Pellerin, A Nordberg, ER Zimmer Trends in molecular medicine 25 (2), 77-95, 2019 | 273 | 2019 |
| [18F]FDG PET signal is driven by astroglial glutamate transport ER Zimmer, MJ Parent, DG Souza, A Leuzy, C Lecrux, HI Kim, S Gauthier, ... Nature neuroscience 20 (3), 393-395, 2017 | 272 | 2017 |
| Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum AL Benedet, M Milà-Alomà, A Vrillon, NJ Ashton, TA Pascoal, F Lussier, ... JAMA neurology 78 (12), 1471-1483, 2021 | 269 | 2021 |
| Cholinergic differentiation of human neuroblastoma SH-SY5Y cell line and its potential use as an in vitro model for Alzheimer’s disease studies LM de Medeiros, MA De Bastiani, EP Rico, P Schonhofen, B Pfaffenseller, ... Molecular neurobiology 56, 7355-7367, 2019 | 177 | 2019 |
| Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging ER Zimmer, A Leuzy, AL Benedet, J Breitner, S Gauthier, P Rosa-Neto Journal of neuroinflammation 11, 1-12, 2014 | 117 | 2014 |
| Exercise increases insulin signaling in the hippocampus: physiological effects and pharmacological impact of intracerebroventricular insulin administration in mice AP Muller, J Gnoatto, JD Moreira, ER Zimmer, CB Haas, F Lulhier, ... Hippocampus 21 (10), 1082-1092, 2011 | 101 | 2011 |
| Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease NJ Ashton, AL Benedet, TA Pascoal, TK Karikari, J Lantero-Rodriguez, ... EBioMedicine 76, 2022 | 99 | 2022 |
| Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease B Bellaver, G Povala, PCL Ferreira, JP Ferrari-Souza, DT Leffa, ... Nature medicine 29 (7), 1775-1781, 2023 | 98 | 2023 |
| Reduced brain insulin-like growth factor I function during aging AP Muller, AM Fernandez, C Haas, E Zimmer, LV Portela, I Torres-Aleman Molecular and Cellular Neuroscience 49 (1), 9-12, 2012 | 95 | 2012 |
| Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis B Bellaver, JP Ferrari-Souza, L Uglione da Ros, SF Carter, ... Neurology 96 (24), e2944-e2955, 2021 | 90 | 2021 |
| Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography J Therriault, M Vermeiren, S Servaes, C Tissot, NJ Ashton, AL Benedet, ... JAMA neurology 80 (2), 188-199, 2023 | 87 | 2023 |
| Alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates DM Vargas, MA De Bastiani, ER Zimmer, F Klamt Alzheimer's Research & Therapy 10, 1-12, 2018 | 79 | 2018 |
| Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer’s disease AL Benedet, A Leuzy, TA Pascoal, NJ Ashton, S Mathotaarachchi, ... Brain 143 (12), 3793-3804, 2020 | 77 | 2020 |
| Amyloid‐β oligomers in cellular models of Alzheimer’s disease IC Fontana, AR Zimmer, AS Rocha, G Gosmann, DO Souza, MV Lourenco, ... Journal of Neurochemistry 155 (4), 348-369, 2020 | 76 | 2020 |
| Guanosine anxiolytic-like effect involves adenosinergic and glutamatergic neurotransmitter systems RF Almeida, DD Comasseto, DB Ramos, G Hansel, ER Zimmer, ... Molecular neurobiology 54, 423-436, 2017 | 74 | 2017 |
| Synaptic vesicle protein 2A as a potential biomarker in synaptopathies K Heurling, NJ Ashton, A Leuzy, ER Zimmer, K Blennow, H Zetterberg, ... Molecular and Cellular Neuroscience 97, 34-42, 2019 | 72 | 2019 |
| Consequences of metabolic disruption in Alzheimer's disease pathology JC Ryu, ER Zimmer, P Rosa-Neto, SO Yoon Neurotherapeutics 16 (3), 600-610, 2019 | 71 | 2019 |
| Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid‐positive individuals AL Benedet, NJ Ashton, TA Pascoal, A Leuzy, S Mathotaarachchi, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 11 (1 …, 2019 | 70 | 2019 |
| Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease JP Ferrari-Souza, PCL Ferreira, B Bellaver, C Tissot, YT Wang, DT Leffa, ... Molecular psychiatry 27 (11), 4781-4789, 2022 | 68 | 2022 |
Pedro Rosa-NetoProfessor, McGill University在 mcgill.ca 的电子邮件经过验证
